| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |